- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03039738
Surveillance Monitoring as an Alternative to Telemetry
April 29, 2019 updated by: Medtronic - MITG
A Prospective Evaluation of Surveillance Monitoring as an Alternative to Telemetry in Patients Scheduled for Telemetry Without American Heart Association (AHA) Indication
The purpose of the study is to evaluate the impact of surveillance monitoring versus telemetry monitoring on clinical, healthcare economics, resource utilization, and qualitative outcomes.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
This will be single-center, prospective, pilot, pre/post implementation study to collect post-market data on hospitalized subjects monitored via telemetry and surveillance monitoring
Study Type
Interventional
Enrollment (Actual)
206
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63130
- Washington University in Saint Louis
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Signed and dated informed consent by subject
- Male or female 18 years of age or older
- Expected hospitalized admission on the general care floor or medical surgical unit for at least one overnight stay and/or > 12 hours
- Scheduled for telemetry monitoring
- Diagnosis indicates American Heart Association (AHA) telemetry Class III or none and therefore not indicated for telemetry monitoring
- For surveillance monitoring group subjects, treating provider who scheduled subject for telemetry agrees to alternative monitoring plan of surveillance monitoring
- Willingness to have study devices attached and hair shaved at sensor location as needed during study participation
- Willingness to participate in all aspects of the study
Exclusion Criteria:
- Implanted pacemaker or atrial defibrillator
- Allergy or sensitivity to ECG leads or adhesives that are similar to ECG leads
- Current AHA Class I or II indication/prescription for telemetry monitoring
- Prescription for other continuous condition monitoring such as capnography or pulse oximetry
- Ongoing opioid therapy by patient-controlled analgesia (PCA), by epidural or intrathecal infusions or by intravenous analgesia, per Investigator discretion
- Ventilated or intubated patients at the time of enrollment
- Female subject is pregnant, lactating, trying to get pregnant, or has a positive pregnancy test for women with childbearing potential
- Condition that, in the opinion of the investigator, may prevent completion of the study or protocol requirements
- Subject is considered as being morbidly obese (defined as BMI >50.0)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Telemetry Monitoring Arm
The telemetry group will serve as the control group and will be monitored via the site's standard of care telemetry protocols.
|
Continuous ECG monitoring for hospitalized patients at-risk for cardiac events.
|
EXPERIMENTAL: Surveillance Monitoring Arm
Subjects in the surveillance monitoring group will alternatively be admitted to medical surgical unit and be monitored via the surveillance monitoring platform.
|
The Vital Sync™ Informatics Manager (IM) & Virtual Patient Monitoring Platform (VPMP) is an electronic medical record connectivity and remote continuous patient monitoring software solution.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospital Length of Stay (LOS) as Assessed by Review of Medical Records
Time Frame: Baseline to end of hospital stay (or up to 30 day post enrollment)
|
LOS will be determined by comparing LOS Between the Surveillance Monitoring and Telemetry Monitoring Period Arms.
|
Baseline to end of hospital stay (or up to 30 day post enrollment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Associated Health Care Costs (HCC) as Determined by Review of Billing Records
Time Frame: Baseline to end of hospital stay (or up to 30 days post enrollment)
|
Health Care Costs will be determined by comparing HCC between the surveillance monitoring and telemetry monitoring arms
|
Baseline to end of hospital stay (or up to 30 days post enrollment)
|
Number of Participants With Hospital Unit Transfers (HUT) as Determined by Review of Medical Records
Time Frame: Baseline to end of hospital stay (or up to 30 days post enrollment)
|
Hospital Unit Transfers (HUT) will be determined by comparing the number of hospital unit transfers between monitoring arms.
|
Baseline to end of hospital stay (or up to 30 days post enrollment)
|
Length of Stay (LOS) in the ICU as Determined by Review of Medical Records
Time Frame: Baseline to end of hospital stay (or up to 30 days post enrollment)
|
Length of Stay in the ICU will be determined by comparing numbers between monitoring arms.
|
Baseline to end of hospital stay (or up to 30 days post enrollment)
|
Number of Participants With Clinical Interventions (CI) as Determined by Review of Medical Records
Time Frame: Baseline to end of hospital stay (or up to 30 days post enrollment)
|
CI include Rapid Response Team calls and Code Blue Activations.
The Number of Clinical Interventions will be determined by comparing numbers between monitoring arms.
|
Baseline to end of hospital stay (or up to 30 days post enrollment)
|
Time of Rapid Response Team Activation to Time of a Threshold Notification as Measured by the Surveillance Monitoring System Only
Time Frame: Baseline to end of hospital stay (or up to 30 days post enrollment)
|
Time of Rapid Response Team (RRT) will be determined by comparing the number of RRT interventions between monitoring arms (only for surveillance monitoring arm)
|
Baseline to end of hospital stay (or up to 30 days post enrollment)
|
Clinical Team and Patient Satisfaction as Measured by Qualitative Questionnaires
Time Frame: Baseline to end of hospital stay (or up to 30 days post enrollment)
|
Clinical Team and Patient Satisfaction will be determined by comparing the Qualitative Questionnaire response between monitoring arms.
|
Baseline to end of hospital stay (or up to 30 days post enrollment)
|
Clinicians Familiarity With AHA Guidelines and Telemetry Utilization as Measured by Qualitative Questionnaires
Time Frame: Baseline to end of hospital stay (or up to 30 days post enrollment)
|
Number of clinicians "very familiar" and "somewhat familiar" with AHA guidelines was reported.
The questionnaire was administered to all clinicians (e.g.
ED physicians, nurses, critical care nurses, intensivists, and hospitalists) involved in the care of study participants at each hospital; it was not administered to study subjects.
|
Baseline to end of hospital stay (or up to 30 days post enrollment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stacey House, MD, PhD, Washington University in Saint Louis
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 3, 2017
Primary Completion (ACTUAL)
January 4, 2018
Study Completion (ACTUAL)
January 4, 2018
Study Registration Dates
First Submitted
January 30, 2017
First Submitted That Met QC Criteria
January 30, 2017
First Posted (ESTIMATE)
February 1, 2017
Study Record Updates
Last Update Posted (ACTUAL)
May 13, 2019
Last Update Submitted That Met QC Criteria
April 29, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- COVMOPO0561
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Monitoring
-
GE HealthcareNot yet recruitingPatient Monitoring
-
Assiut UniversityRecruitingPatient MonitoringEgypt
-
Asan Medical CenterKorea Health Industry Development InstituteCompletedPatient MonitoringKorea, Republic of
-
Azienda Socio Sanitaria Territoriale del GardaASL Roma 6Unknown
-
University of UtahCompletedPatient Monitoring | Oxygen Delivery | Patient ComfortUnited States
-
University of UtahActive, not recruiting
-
Tel-Aviv Sourasky Medical CenterCompleted
-
Uskudar UniversityCompletedMaternal Health | Fetal Monitoring | Patient ComfortTurkey
-
Edwards LifesciencesCompleted
Clinical Trials on Telemetry Monitoring
-
Carilion ClinicJohns Hopkins University; Virginia Commonwealth University; Medstar Health Research... and other collaboratorsWithdrawnChest Pain | Acute Coronary Syndrome | Telemetry | Health Care Resource Utilization
-
Turtle Shell Technologies Pvt. Ltd.Eastside Research Associates; HealthMindsCompletedNo Specific Medical Conditions or Disease StatesUnited States
-
Carilion ClinicNot yet recruitingArrhythmias, Cardiac | Arrhythmia | Syncope | Near Syncope
-
Turtle Shell Technologies Pvt. Ltd.Louisiana State University Health Sciences Center in New Orleans; HealthMindsTerminatedNo Specific Medical Conditions or Disease StatesUnited States
-
Atlantic Health SystemUnknownHypertrophic CardiomyopathyUnited States
-
Dana-Farber Cancer InstituteAstraZenecaNot yet recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Karolinska InstitutetPhilips Healthcare; University of Stellenbosch; ER24CompletedMyocardial Infarction | STEMISouth Africa
-
Sunnybrook Health Sciences CentreMotorola Canada LimitedCompletedBipolar Disorder | Borderline Personality Disorder | CyclothymiaCanada
-
Unity Health TorontoTerminatedAtrial Fibrillation | Arrhythmias, Cardiac | Atrial Flutter | C.Surgical Procedure; CardiacCanada
-
Hopital FochTerminated